| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |